Results 111 to 120 of about 3,195 (172)

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

open access: yesAggregate, Volume 6, Issue 9, September 2025.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang   +6 more
wiley   +1 more source

Investigating the Chemical–Biological Link in Ziziphora galinae Extracts for the Discovery of Novel Raw Materials via In Silico and In Vitro Assays

open access: yesFood Science &Nutrition, Volume 13, Issue 9, September 2025.
Ziziphora galinae may be attributed to the presence of distinct compounds, making them a valuable source of bioactive compounds to benefit human health. ABSTRACT This study examined the impact of the extraction methods (70% ethanolic extraction, infusion) on the overall biological profile and concentration of phenolic compounds of Ziziphora galinae (ZG)
Serdar Korpayev   +9 more
wiley   +1 more source

Nosocomial infections by diverse carbapenemase-producing Aeromonas hydrophila associated with combination of plumbing issues and heat waves [PDF]

open access: yes
BackgroundAquatic opportunistic pathogen Aeromonas hydrophila, known to persist in low-nutrient chlorinated waters, can cause life-threatening infections.
Beaird, Omer E   +9 more
core   +1 more source

DOMINANCE OF blaOXA-48-LIKE AMONG CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE ISOLATED FROM ABU DHABI HOSPITALS [PDF]

open access: yes, 2023
Antibiotic resistance is a major concern for public health worldwide due to its associated morbidity and mortality, which is primarily attributed to the inappropriate use of antibiotics. This, in turn, leads to the evolution of bacteria which can develop
Baig, Mohammed Awase
core   +1 more source

Emerg Infect Dis [PDF]

open access: yes
2018PMC5875283702

core  

Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai

open access: yesInfection and Drug Resistance, 2018
Dongxing Tian, Fen Pan, Chun Wang, Yan Sun, Hong Zhang Department of Clinical Laboratory, Shanghai Children’s Hospital, Shanghai Jiaotong University, Shanghai, China Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) has caused wide ...
Tian D, Pan F, Wang C, Sun Y, Zhang H
doaj  

EMERGENCE OF CARBAPENEM RESISTANT ENTEROBACTERIACEAE IN ABU DHABI, 2009-2015 [PDF]

open access: yes, 2018
The rapid emergence of carbapenem resistant Enterobacteriaceae (CRE) is a global phenomenon that has not spared the United Arab Emirates. However, unlike in most Western countries with similarly developed health care system, very little data have been ...
Butt, Aqdas Bilal
core   +1 more source

Molecular analysis of carbapenemase-producing Pseudomonas aeruginosa strains in a tertiary care hospital in Riyadh

open access: yesJournal of Infection and Public Health
Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) presents a significant obstacle to effective antimicrobial treatment, particularly when resistance is driven by carbapenemase-producing strains (CPPA).
Hanan O. Alshammari   +5 more
doaj   +1 more source

Emergence of OXA-232-producing hypervirulent Klebsiella pneumoniae ST23 causing neonatal sepsis

open access: yesJournal of Antimicrobial Chemotherapy, 2020
Subhankar, Mukherjee   +6 more
openaire   +2 more sources

In vitro activity of ceftazidime–avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020

open access: yesMicrobiology Spectrum
Oxacillinases (OXA)-48-like β-lactamases are one of the most common resistance determinants among carbapenem-resistant Enterobacterales reported globally. Moreover, there is no standard treatment available against organisms producing OXA-48-like enzymes,
Gregory Stone, Mark Wise, Eric Utt
doaj   +1 more source

Home - About - Disclaimer - Privacy